1 matches for your search in the start-up spotlight
rss
matching the following criteria
Sort by:
CyGenica Limited
CyGenica uses a non-viral, non-toxic platform to develop in vitro and in vivo delivery solutions for drugs, gene editing components, and antibiotics. The most crucial issue of intracellular delivery for large molecules, especially for gene therapy, remains the cellular membrane. This biological ...
